Adding to our recent successes with licencing PromarkerD into the USA and Mexico, we are pleased to announce a new licence deal with Patia Europe for Spain.
The agreement with Patia builds on their strong relationships in diabetes research with the Carlos Slim Foundation, Harvard University and the Massachusetts Institute of Technology (MIT).
We are also proud to announce that Proteomics International has won the WA Export Award in the Health and Biotechnology category. The Award reflects our company’s innovative products and export derived revenue doubling to $795,000 in FY18.
